RECIPIENT-TO-DONOR ANTI-CMV IGG RATIO AS A PREDICTOR OF CMV REACTIVATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE-CONTROL STUDY. Mediterr J Hematol Infect Dis [Internet]. 2026 Oct. 31 [cited 2026 Nov. 1];18(1):e2026078. Available from: https://www.mjhid.org/mjhid/article/view/6454